Compounds that target novel cellular components involved in HIV-1 transcription.

Molecular medicine (Cambridge, Mass.)

Volumn 1, Issue 7, 1995, Pages 758-767

  Butera, S T ^a   Roberts, B D ^a   Critchfield, J W ^a   Fang, G ^a   McQuade, T ^a   Gracheck, S J ^a   Folks, T M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PD 121871; PD 144795; PHORBOL ESTER; THIOPHENE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL LINE; DOSE RESPONSE; DRUG EFFECT; DRUG INTERACTION; GENETIC TRANSCRIPTION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; METABOLISM; VIRUS LATENCY;

ANTIVIRAL AGENTS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HIV-1; NF-KAPPA B; PHORBOL ESTERS; THIOPHENES; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; VIRUS LATENCY;

MLCS; MLOWN;

EID: 0029401860     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401890     Document Type: Article

References (0)